Skip Navigation LinksSkip Navigation Links
Centers for Disease Control and Prevention
Safer Healthier People
Blue White
Blue White
bottom curve
CDC Home Search Health Topics A-Z spacer spacer
spacer
Blue curve MMWR spacer
spacer
spacer

The content on this page is being archived for historic and reference purposes only. The content, links, and pdfs are no longer maintained and might be outdated.

Notice to Readers Changes in CPT Code for Hepatitis Panel Causing Delayed Reports of Acute Hepatitis

Current Procedural Terminology (CPT) codes are standardized codes developed and maintained by the CPT Board of the American Medical Association for reporting medical services. The Health Care Financing Administration requires use of these codes in the Common Procedure Coding System when services are reported to Medicare and Medicaid for reimbursement. Effective January 1, 1998, the CPT Board changed the hepatitis serology panel (CPT#80059) to exclude the tests for IgM antibody to hepatitis A virus (IgM anti-HAV) and IgM antibody to hepatitis B core antigen (IgM anti-HBc). These two tests specifically identify recent infection with HAV and HBV, respectively. Many providers may be unaware that these tests are not part of the standard hepatitis panel, and diagnoses of cases of acute viral hepatitis are likely to be delayed by the need to perform additional testing. As a result, reporting of cases to health departments may be delayed, and CDC has received reports of instances of insufficient time to provide postexposure prophylaxis to prevent transmission of HAV or HBV to susceptible contacts of the case-patient.

The CPT Board has revised the hepatitis serology panel to include both IgM tests that were deleted. However, these modifications will not be implemented until the next CPT code manual is issued on January 1, 2000. Until this change takes effect, health departments should notify health-care practitioners and/or laboratories of the need to order individual tests for IgM anti-HAV (CPT#86709) and IgM anti-HBc (CPT#86705) for accurate determination of the cause of illness in patients with signs and/or symptoms of acute viral hepatitis and for timely prophylaxis of contacts.


Disclaimer   All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

Page converted: 04/29/99

HOME  |  ABOUT MMWR  |  MMWR SEARCH  |  DOWNLOADS  |  RSSCONTACT
POLICY  |  DISCLAIMER  |  ACCESSIBILITY

Safer, Healthier People

Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention
1600 Clifton Rd, MailStop E-90, Atlanta, GA 30333, U.S.A

USA.GovDHHS

Department of Health
and Human Services

This page last reviewed 5/2/01